Thyrocare Tech.
Ticker > Company >

Thyrocare Tech. share price

Thyrocare Technologies Ltd.

NSE: THYROCARE BSE: 539871 SECTOR: Hospital & Healthcare Services  138k   564   69

903.80
0 0
BSE: 25 Apr 04:01 PM

Price Summary

Today's High

₹ 938.85

Today's Low

₹ 830.9

52 Week High

₹ 1053.05

52 Week Low

₹ 570.75

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 4789.55 Cr.

Enterprise Value

₹ 4775.22 Cr.

No. of Shares

5.3 Cr.

P/E

50.01

P/B

8.92

Face Value

₹ 10

Div. Yield

2.32 %

Book Value (TTM)

₹  101.35

CASH

₹ 34.1 Cr.

DEBT

₹ 19.77 Cr.

Promoter Holding

71.06 %

EPS (TTM)

₹  18.07

Sales Growth

7.72%

ROE

13.87 %

ROCE

19.55%

Profit Growth

24.87 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Brands

These are the brands of Thyrocare Technologies Ltd.

Aarogyam WHATERS

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year7.72%
3 Year3.38%
5 Year7.19%

Profit Growth

1 Year21.96%
3 Year-15.52%
5 Year-5.63%

ROE%

1 Year13.87%
3 Year18.86%
5 Year21.02%

ROCE %

1 Year19.55%
3 Year26.52%
5 Year29.21%

Debt/Equity

0.0388

Price to Cash Flow

30.86

Interest Cover Ratio

21.127

CFO/PAT (5 Yr. Avg.)

1.31098591549296

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2025 71.06 100.00
Dec 2024 71.06 100.00
Sep 2024 71.11 100.00
Jun 2024 71.11 100.00
Mar 2024 71.11 100.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company has been maintaining healthy ROCE of 26.5181276724352% over the past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 21.127.
  • The Company has been maintaining an effective average operating margins of 33.6653455371464% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of 1.07560000000001 days.
  • Company has a healthy liquidity position with current ratio of 3.2339.
  • The company has a good cash flow management; CFO/PAT stands at 1.31098591549296.

 Limitations

  • The company has shown a poor profit growth of -15.9401513416487% for the Past 3 years.
  • The company has shown a poor revenue growth of 3.38096739615257% for the Past 3 years.
  • The company is trading at a high PE of 50.01.
  • Promoter pledging is high as 100%.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
Net Sales 141.23 143.63 163.05 152.55 173.87
Total Expenditure 107.64 101.28 114.26 112.3 118.23
Operating Profit 33.59 42.35 48.79 40.25 55.64
Other Income 2.81 3.17 2.12 3.51 4.54
Interest 0.94 0.93 0.63 0.48 0.6
Depreciation 10.41 9.45 9.94 15.34 11.78
Exceptional Items 0 0 0 0 0
Profit Before Tax 25.05 35.14 40.34 27.94 47.8
Tax 5.82 9.99 10.75 8.84 25.85
Profit After Tax 19.23 25.15 29.59 19.1 21.95
Adjusted EPS (Rs) 3.63 4.75 5.59 3.6 4.14

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 401.06 474.27 561.53 486.46 524.02
Total Expenditure 233.29 303.53 330 372.16 389
Operating Profit 167.77 170.74 231.53 114.3 135.02
Other Income 9.42 12.28 7.4 5.39 7.18
Interest 1.32 0.66 3.08 4.54 4.88
Depreciation 19.54 21.08 28.47 34.08 39.1
Exceptional Items -44.33 0 0 0 0
Profit Before Tax 112 161.28 207.38 81.07 98.22
Tax 32.68 41.51 55.33 24.1 27.08
Net Profit 79.44 118.36 152.01 58.51 71.36
Adjusted EPS (Rs.) 15.01 22.65 28.74 10.76 13.44

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 52.84 52.87 52.9 52.93 52.95
Total Reserves 325.39 392.59 467.8 468.11 460.86
Borrowings 0 0 0 0 10.91
Other N/C liabilities 1.77 4.78 0.43 138.04 -4.58
Current liabilities 50.75 62.69 211.03 145.88 75.96
Total Liabilities 430.75 512.93 732.16 804.96 596.1
Assets
Net Block 110.39 118.03 148.31 155.63 158.29
Capital WIP 3.87 8.28 2.15 0.82 0.76
Intangible WIP 0 0 0 0 0
Investments 170.34 170.34 170.34 172.75 176.2
Loans & Advances 27.67 29.06 23.77 163.54 12.91
Other N/C Assets 5.21 4.72 5.83 3.02 2.29
Current Assets 113.27 182.5 381.76 309.2 245.65
Total Assets 430.75 512.93 732.16 804.96 596.1
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 156.33 161.28 207.38 81.07 98.22
Adjustment 15.76 14.16 38.05 63.4 63.77
Changes in Assets & Liabilities 8.49 -20.78 -83.43 4.25 22.19
Tax Paid -44.25 -43.59 -56.32 -28.7 -28.99
Operating Cash Flow 136.33 111.07 105.68 120.02 155.19
Investing Cash Flow 26.84 -53.09 -12.32 -31.65 -80.29
Financing Cash Flow -162.65 -57.81 -86.91 -87.5 -83.71
Net Cash Flow 0.52 0.17 6.45 0.87 -8.81

Corporate Actions

Investors Details

PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
promoters 71.11 71.11 71.11 71.06 71.06
docon technologies privat... 71.11 71.11 71.11 71.06 71.06
PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
investors 28.89 28.89 28.89 28.94 28.94
dsp india t.i.g.e.r. fund... - - - - 1.22
icici prudential pharma h... - 4.15 3.37 2.75 2.65
llp 0.13 0.14 0.07 0.09 0.08
nippon life india trustee... 7.30 6.69 7.06 7.05 7.05
quant mutual fund - quant... - 1.39 1.80 2.08 1.96
theleme india master fund... 1.41 1.36 - - -
icici prudential india op... 4.98 - - - -

Annual Reports

Ratings & Research Reports

Company Presentations

Company News

Thyrocare Technologies informs about press release 23 Apr, 5:35 PM Thyrocare Tech. - Quaterly Results 23 Apr, 4:23 PM Thyrocare Tech. - Quaterly Results 23 Apr, 4:23 PM Thyrocare Technologies makes additional equity investment in Thyrocare Laboratories (Tanzania) 4 Mar, 9:44 AM Thyrocare Tech. - Quaterly Results 3 Feb, 4:04 PM Thyrocare Tech. - Quaterly Results 3 Feb, 4:04 PM Thyrocare Tech. - Quaterly Results 3 Feb, 4:04 PM Thyrocare Tech. - Quaterly Results 23 Jan, 12:00 PM Thyrocare Tech. - Quaterly Results 23 Jan, 12:00 PM Thyrocare Tech. - Quaterly Results 23 Jan, 12:00 PM Thyrocare Technologies makes another equity investment in Thyrocare Laboratories 4 Dec, 10:58 AM Thyrocare Tech. - Quaterly Results 23 Oct, 4:20 PM Thyrocare Tech. - Quaterly Results 23 Oct, 4:20 PM Thyrocare Tech. - Quaterly Results 23 Oct, 4:20 PM Thyrocare Technologies informs about execution of BTA 30 Aug, 3:23 PM Thyrocare Technologies acquires business of Polo 30 Jul, 10:14 AM Thyrocare Tech. - Quaterly Results 23 Jul, 3:57 PM Thyrocare Tech. - Quaterly Results 23 Jul, 3:57 PM Thyrocare Tech. - Quaterly Results 23 Jul, 3:57 PM Thyrocare Technologies informs about disclosure 25 Jun, 4:35 PM Thyrocare Technologies informs about outcome of board meeting 14 May, 5:10 PM Thyrocare Tech. - Quaterly Results 14 May, 3:40 PM Thyrocare Tech. - Quaterly Results 14 May, 3:40 PM Thyrocare Tech. - Quaterly Results 14 May, 3:40 PM Thyrocare Technologies completes acquisition of 100% stake in Think Health 28 Feb, 9:30 AM Thyrocare Technologies informs about appointment of chief commercial officer 23 Feb, 9:50 AM Thyrocare Tech. - Quaterly Results 1 Feb, 5:04 PM Thyrocare Tech. - Quaterly Results 1 Feb, 5:04 PM Thyrocare Tech. - Quaterly Results 1 Feb, 5:04 PM Thyrocare Technologies to acquire 100% stake in Think Health 1 Feb, 4:56 PM Thyrocare Technologies informs about outcome of board meeting 31 Oct, 5:22 PM Thyrocare Tech. - Quaterly Results 31 Oct, 4:39 PM Thyrocare Tech. - Quaterly Results 31 Oct, 4:39 PM Thyrocare Tech. - Quaterly Results 31 Oct, 4:39 PM Thyrocare Technologies enters into Subscription Agreement with Kastipharm 20 Sep, 9:47 AM Thyrocare Tech. - Quaterly Results 1 Aug, 4:35 PM Thyrocare Tech. - Quaterly Results 1 Aug, 4:35 PM Thyrocare Tech. - Quaterly Results 1 Aug, 4:35 PM Thyrocare Technologies informs about disclosure 22 Jun, 10:06 AM Thyrocare Technologies informs about disclosure 8 Jun, 2:22 PM Thyrocare Tech. - Quaterly Results 23 May, 5:29 PM Thyrocare Tech. - Quaterly Results 23 May, 5:29 PM Thyrocare Tech. - Quaterly Results 23 May, 5:29 PM Thyrocare Technologies informs about conference call 17 May, 12:26 PM Thyrocare Technologies informs about analyst meet 25 Apr, 2:09 PM Thyrocare Technologies submits analyst meet intimation 13 Mar, 4:55 PM Thyrocare Technologies informs about disclosure 10 Mar, 3:12 PM Thyrocare Technologies informs about investors meet 27 Feb, 5:09 PM Thyrocare Technologies informs about audio recording of earning call 4 Feb, 10:29 AM Thyrocare Tech. - Quaterly Results 3 Feb, 3:39 PM

Thyrocare Tech. Stock Price Analysis and Quick Research Report. Is Thyrocare Tech. an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Thyrocare Tech. and its performance over the period of time. Thyrocare Tech. stock price today is Rs 902.3.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Thyrocare Tech. cash from the operating activity was Rs 155.19 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Thyrocare Tech. has a Debt to Equity ratio of 0.0388 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Thyrocare Tech. , the EPS growth was 24.8251 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Thyrocare Tech. has OPM of 25.7661921300714 % which is a good sign for profitability.
     
  • ROE: Thyrocare Tech. have a average ROE of 13.8669 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Thyrocare Tech. is Rs 902.3. One can use valuation calculators of ticker to know if Thyrocare Tech. share price is undervalued or overvalued.
Last Updated on:
Brief about Thyrocare Tech.

Thyrocare Technologies Ltd. Financials: Check Share Price, Balance Sheet, Annual Report, Quarterly Results, Shareholding, Company Profile and News for Company Analysis

Thyrocare Technologies Ltd. is a leading diagnostic and preventive care testing company in India. Established in 1995, Thyrocare has emerged as a trusted brand in the pathology sector with a robust network of more than 1 lakh healthcare centres across the country. The company offers a comprehensive range of services that include blood tests, preventive care, and wellness solutions. Thyrocare has built a reputation for providing high-quality services and accurate results at affordable prices.

Thyrocare Technologies Ltd. Share Price

The share price of Thyrocare Technologies Ltd. has displayed an upward trend since its initial public offering (IPO) in 2016. The company's shares were listed on the National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE). As of [insert date], the shares were trading at [insert share price]. Thyrocare Technologies Ltd. has a market capitalization of [insert market cap], making it one of the top-performing stocks in the healthcare sector.

Thyrocare Technologies Ltd. Balance Sheet

Thyrocare Technologies Ltd. has a strong balance sheet, which is reflective of its industry expertise and sound financial management practices. The company has consistently reported robust revenue growth over the past few years, with its net profit increasing by [insert data] percent in [insert year]. Thyrocare's strong balance sheet is a testament to its commitment to maintaining excellent financial health.

Thyrocare Technologies Ltd. Annual Report

Thyrocare Technologies Ltd.'s annual report is a comprehensive document that provides detailed information on the company's operations, financial performance, and future prospects. The annual report for [insert year] can be downloaded from our website and provides investors with insights into the company's overall strategy and performance.

Thyrocare Technologies Ltd. Dividend

Thyrocare Technologies Ltd. has a consistent dividend payment history, making it an attractive investment option for income-seeking investors. The company's board of directors typically meets annually to decide on the dividend payout ratio. Investors can use our pre-built screening tools to evaluate Thyrocare's dividend yield and compare it with other industry players.

Thyrocare Technologies Ltd. Quarterly Result

Thyrocare Technologies Ltd.'s quarterly results provide a snapshot of the company's financial performance over the past few months. The results include key financial metrics such as revenue, earnings, and net profit. Our website provides access to the quarterly results and enables investors to analyse the company's performance over time. Our premium features allow for fair value calculation using tools such as DCF Analysis, BVPS Analysis, Earnings multiple approach, and DuPont analysis.

Thyrocare Technologies Ltd. Stock Price

Thyrocare Technologies Ltd.'s stock price is a crucial indicator of investor sentiment towards the company. The shares have historically shown a stable price trend, making it a consistent performer in the stock market. Investors can use our pre-built screening tools to track Thyrocare's stock price and compare it with other companies in the healthcare industry.

Thyrocare Technologies Ltd. Price Chart

Thyrocare Technologies Ltd.'s price chart is a visual representation of the company's stock price movement over time. Our website provides access to real-time price charts, which can be customized to show historical data, trends, and technical indicators. Price charts are an essential tool for investors to analyze the company's performance and make informed investment decisions.

Thyrocare Technologies Ltd. News

Thyrocare Technologies Ltd. news section provides investors with the latest updates and developments related to the company. The news section is updated regularly and covers a diverse range of topics such as new product launches, partnerships, and collaborations. Our news section is an excellent resource for investors who want to stay up-to-date with the company's activities.

Thyrocare Technologies Ltd. Concall Transcripts

Thyrocare Technologies Ltd.'s concall transcripts are available for download on our website. These transcripts provide investors with a detailed record of the company's earnings calls, which are held every quarter. The concall transcripts include discussions on the company's financial performance, industry trends, and future outlook. Investors can use these transcripts to gain valuable insights into the company's strategy and vision.

Thyrocare Technologies Ltd. Investor Presentations

Thyrocare Technologies Ltd.'s investor presentations are available for download on our website. These presentations provide a comprehensive overview of the company's operations, strategy, and performance. The presentations include key financial metrics, industry analysis, and forecasts. Investors can use Thyrocare's investor presentations to make informed investment decisions and assess the company's growth prospects.

Thyrocare Technologies Ltd. Promoters

Thyrocare Technologies Ltd.'s promoters are a group of highly experienced professionals who have been instrumental in the company's growth and success. The promoters include entrepreneurs, industry professionals, and experts with significant experience in the healthcare sector. The promoters of Thyrocare are committed to maintaining the company's reputation for quality and accuracy and have been successful in delivering consistent shareholder value.

Thyrocare Technologies Ltd. Shareholders

Thyrocare Technologies Ltd.'s shareholders include a diverse range of institutional and retail investors. The shareholders have reposed their trust in the company's management team and are confident of the company's prospects. Thyrocare's shareholders have been rewarded with consistent returns and steady capital appreciation over time.

In conclusion, Thyrocare Technologies Ltd. is a leading diagnostic and preventive care testing company in India. The company has a strong reputation for providing high-quality services at affordable prices and has consistently delivered strong financial performance. Investors can use our pre-built screening tools to evaluate the company's financial metrics and make informed investment decisions. Our website provides access to Thyrocare's annual reports, concall transcripts, investor presentations, credit ratings, and research reports, allowing investors to keep track of the company's performance and growth prospects. Our premium features, including fair value calculation tools, enable investors to perform a detailed analysis of the company's balance sheet, quarterly results, and profit and loss statements. 

Thyrocare Technologies Balance Sheet Analysis

Thyrocare Technologies, a prominent player in the healthcare sector, exhibits a robust balance sheet, revealing key financial insights over the past four years. Looking at the company's reserves, there is an evident growth trajectory from Rs 325.39 Cr in March 2020 to Rs 460.86 Cr by March 2024. However, it's worth noting that after reaching a peak in March 2023 at Rs 468.11 Cr, there was a slight decline by March 2024.

Thyrocare Technologies Debt Introduction

Interestingly, Thyrocare Technologies remained debt-free until March 2023, when borrowings entered the scene at just under Rs 11 Cr. This introduction of debt highlights a potential strategic shift in the company's capital structure, possibly indicating investment or expansion activities that could affect future growth.

Thyrocare Technologies Asset Growth

The asset side of the balance sheet reflects a positive outlook, with the net block increasing from Rs 110.39 Cr in March 2020 to Rs 158.29 Cr by March 2024, signaling ongoing investment in property, plant, and equipment. Furthermore, investments grew steadily to Rs 176.20 Cr, pointing towards effective capital allocation.

Current Assets and Liabilities

A significant jump was observed in current assets from Rs 113.27 Cr in March 2020 to Rs 381.76 Cr in March 2022, before settling at Rs 245.65 Cr by March 2024. Current liabilities followed a somewhat erratic pattern, peaking in March 2022 at Rs 211.03 Cr and later receding to Rs 75.96 Cr.

Reflecting on Thyrocare's Financial Health

The data presents an analysis for the Standalone Balance Sheet of Thyrocare Technologies. It is integral for investors to monitor such financial movements within healthcare entities like Thyrocare Technologies, amidst market trends and sectoral shifts, aiding in informed decision-making without suggesting any investment action.

Note: This analysis allows investors to screen for potential opportunities and understand the financial standings of Thyrocare Technologies relative to market trends and indices such as the BSE and NSE. 

Thyrocare Technologies Reserves

Between Mar 2020 and Mar 2023, Thyrocare Technologies showcased a notable increase in its total reserves, climbing from Rs 325.39 Cr to Rs 468.11 Cr. However, there was a slight decline observed in Mar 2024, with reserves standing at Rs 460.86 Cr.

Thyrocare Technologies Balance Sheet Evolution

Reviewing Thyrocare Technologies’ balance sheet over the span of four years, from Mar 2020 to Mar 2024, the company has managed to significantly increase its total liabilities and assets from Rs 430.75 Cr to Rs 596.10 Cr. This indicates overall growth in the size of the company's financial stature.

Thyrocare Technologies Debt Profile

A substantial change in Thyrocare Technologies' borrowing status was observed in Mar 2024, where the figure went from zero to Rs 10.91 Cr, marking the introduction of debt into the company's capital structure.

Thyrocare Technologies Assets Analysis

In terms of assets, there has been a steady increase in Thyrocare Technologies' net block from Rs 110.39 Cr in Mar 2020 to Rs 158.29 Cr in Mar 2024, showing growth in the company's property and equipment investments. Current assets saw a peak at Rs 381.76 Cr in Mar 2022 before reducing to Rs 245.65 Cr in Mar 2024.

The data is an analysis for the Standalone Balance Sheet of the company.

In the context of market dynamics, Thyrocare Technologies forms part of the healthcare sector, which is often monitored by investors for its potential resistance to economic downturns and as a gauge for the sector's innovation.

Read More
X